Literature DB >> 33505130

Anti-Atherosclerotic and Anti-Inflammatory Effects of Curcumin on Hypercholesterolemic Male Rabbits.

Murooj L Majeed1, Fadhaa A Ghafil1, Ghizal Fatima2, Najah R Hadi1, Hind F Mahdi3.   

Abstract

Curcumin has a potent antioxidant and anti-inflammatory properties that may suppress inflammatory component of atherosclerosis. It has been demonstrated that curcumin derivatives can reduce the formation of arterial fatty streaks in cholesterol-fed rabbits. Therefore in this study we evaluated the protective effects of Curcumin on the progression of atherosclerosis. 20 mature rabbits were included for this study; they were randomly divided into four groups each of 5. Group 1: (normal control) were fed corn pellets diet and tab water, group 2: (high cholesterol diet control) were kept on cholesterol rich diet (2% cholesterol) and tab water. Group 3: (cholesterol and rosuvastatin treated group) were kept on cholesterol rich diet (2% cholesterol) and 2.5 mg/kg/day Rosuvastatin dispersed in DW and given orally, group 4: (cholesterol and curcumin treated group) were kept on cholesterol rich diet (2% cholesterol) and 0.2% curcumin added with corn pellets. The study continued for 12 weeks then assessment of serum level of high sensitive C-reactive protein, ICAM1, VCAM1 and PCSK9 was carried out at the end of the study. Total antioxidant activity of curcumin was also determined. Histopathological examination of aortic tissues for atherosclerotic changes was also carried out. Atherogenic (cholesterol rich diet) induced an increment in serum level of TC, LDL, VLDL and TG with concomitant decrement in serum level of HDL and increased atherogenic index. Treatment with curcumin produced substantial reduction in serum TC, LDL, TG with no effect on HDL level thus decreased atherogenic index. Rabbits treated with curcumin showed a significant reduction in the serum level of high sensitive C-reactive protein, ICAM1, VCAM, PCSK9 serum expression and aortic total antioxidant capacity. Curcumin has a potent anti-inflammatory and anti- oxidant effects against atherosclerosis so exerts a protective role by decreasing lipid oxidation and inflammatory markers. © Association of Clinical Biochemists of India 2019.

Entities:  

Keywords:  Anti-inflammatory; Curcumin; Hypercholesterolemic; Male; Rabbits

Year:  2019        PMID: 33505130      PMCID: PMC7817719          DOI: 10.1007/s12291-019-00858-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  16 in total

Review 1.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 2.  PCSK9 inhibitors - mechanisms of action.

Authors:  Michael M Page; Gerald F Watts
Journal:  Aust Prescr       Date:  2016-10-01

3.  Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Yan Zhao; Keita Fukao; Songji Zhao; Ayahisa Watanabe; Tadateru Hamada; Kazuaki Yamasaki; Yoichi Shimizu; Naoki Kubo; Naoyuki Ukon; Toru Nakano; Nagara Tamaki; Yuji Kuge
Journal:  Mol Imaging       Date:  2015       Impact factor: 4.488

4.  Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism.

Authors:  Su-Kyung Shin; Tae-Youl Ha; Robin A McGregor; Myung-Sook Choi
Journal:  Mol Nutr Food Res       Date:  2011-11-07       Impact factor: 5.914

5.  Tissue concentrations and interaction of zinc with lead toxicity in rabbits.

Authors:  E Hietanen; A Aitio; U Koivusaari; J Kilpiö; T Nevalainen; M Närhi; H Savolainen; H Vainio
Journal:  Toxicology       Date:  1982       Impact factor: 4.221

Review 6.  Role of PCSK9 in lipid metabolism and atherosclerosis.

Authors:  Xiao-Long Lin; Le-Le Xiao; Zhi-Han Tang; Zhi-Sheng Jiang; Mi-Hua Liu
Journal:  Biomed Pharmacother       Date:  2018-05-11       Impact factor: 6.529

Review 7.  New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.

Authors:  Meng-Yu Wu; Chia-Jung Li; Ming-Feng Hou; Pei-Yi Chu
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

Review 8.  Lipid Lowering Therapy and Circulating PCSK9 Concentration.

Authors:  Tsuyoshi Nozue
Journal:  J Atheroscler Thromb       Date:  2017-08-14       Impact factor: 4.928

Review 9.  PCSK9 and triglyceride-rich lipoprotein metabolism.

Authors:  I Druce; H Abujrad; T C Ooi
Journal:  J Biomed Res       Date:  2015-07-20

Review 10.  Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology.

Authors:  Sarah Aldosari; Maan Awad; Elizabeth O Harrington; Frank W Sellke; M Ruhul Abid
Journal:  Antioxidants (Basel)       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.